PHAT
Asset Logo

PHATHOM PHARMACEUTICALS INC

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-5.68%
Annual Growth

5 years average annual growth

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s pipeline product candidate, VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

📈 Performance

Price History*

-21.98%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$18.95

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in PHAT

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

29 weeks

💵 Average investment amount

$630

Last time a customer invested in PHAT

141 days
PHAT investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

50%

Less than 50k

50%
👶 Age of investors

18 - 25

50%

26 - 34

35 - 90

50%
🙋 Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in PHAT also invest in...

Apple, Inc.

AAPL

🙌 Performance (5Yr p.a)

49.07%

📊 Share price

$222.01 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

36.55%

📊 Share price

$408.46 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

499.46%

📊 Share price

$136.06 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

4.12%

📊 Share price

$50.56 USD

🙌 Performance (5Yr p.a)

1027.50%

📊 Share price

$169.24 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-0.86%

📊 Share price

$18.23 USD

📊 Share price

$8.34 USD
Compare
Add to watchlist